Geode Capital Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.19M | Buy |
2,984,045
+319,679
| +12% | +$771K | ﹤0.01% | 2545 |
|
|
2025
Q1 | $5.89M | Sell |
2,664,366
-130,595
| -5% | -$289K | ﹤0.01% | 2584 |
|
|
2024
Q4 | $15.2M | Buy |
2,794,961
+42,884
| +2% | +$234K | ﹤0.01% | 2112 |
|
|
2024
Q3 | $22.9M | Buy |
2,752,077
+162,601
| +6% | +$1.35M | ﹤0.01% | 1915 |
|
|
2024
Q2 | $18.5M | Buy |
2,589,476
+761,564
| +42% | +$5.45M | ﹤0.01% | 1966 |
|
|
2024
Q1 | $15.9M | Buy |
1,827,912
+59,901
| +3% | +$519K | ﹤0.01% | 2060 |
|
|
2023
Q4 | $11.6M | Buy |
1,768,011
+63,109
| +4% | +$413K | ﹤0.01% | 2250 |
|
|
2023
Q3 | $17.1M | Sell |
1,704,902
-56,983
| -3% | -$570K | ﹤0.01% | 1926 |
|
|
2023
Q2 | $21.9M | Buy |
1,761,885
+63,852
| +4% | +$794K | ﹤0.01% | 1792 |
|
|
2023
Q1 | $23.8M | Buy |
1,698,033
+17,511
| +1% | +$245K | ﹤0.01% | 1676 |
|
|
2022
Q4 | $24M | Buy |
1,680,522
+12,436
| +0.7% | +$178K | ﹤0.01% | 1649 |
|
|
2022
Q3 | $42.6M | Buy |
1,668,086
+38,486
| +2% | +$983K | 0.01% | 1193 |
|
|
2022
Q2 | $46.3M | Buy |
1,629,600
+149,020
| +10% | +$4.23M | 0.01% | 1186 |
|
|
2022
Q1 | $52.2M | Buy |
1,480,580
+54,286
| +4% | +$1.91M | 0.01% | 1226 |
|
|
2021
Q4 | $59.8M | Buy |
1,426,294
+90,917
| +7% | +$3.81M | 0.01% | 1175 |
|
|
2021
Q3 | $65.5M | Buy |
1,335,377
+214,221
| +19% | +$10.5M | 0.01% | 1046 |
|
|
2021
Q2 | $46.8M | Buy |
1,121,156
+323,948
| +41% | +$13.5M | 0.01% | 1370 |
|
|
2021
Q1 | $28.4M | Buy |
797,208
+732,770
| +1,137% | +$26.1M | ﹤0.01% | 1655 |
|
|
2020
Q4 | $1.81M | Buy |
+64,438
| New | +$1.81M | ﹤0.01% | 3141 |
|